Purchase Order 75N93018P01079
- Not listed
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division valued at $149,999.00. The contract is for the delivery of a BIO-RAD S3E CELL SORTER 488/640-2L4D to support biomedical research at the agency's facilities in Hercules, California. Bio-Rad Laboratories, a leading manufacturer of life science research products and clinical...
- This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc., was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $10,390.00 firm fixed-price purchase order does not have a set-aside designation. The award is associated with Bio-Rad's $1 billion Blanket Purchase Agreement with the NIH Office of Logistics and Acquisition...
- This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc., was issued by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Office of Acquisitions. The $26,949.12 firm fixed price purchase order does not have a set-aside designation. The contract is for the delivery of laboratory equipment, reagents, and consumables to support biomedical research and testing. Bio-Rad...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $14,664 firm fixed price purchase order to Bio-Rad Laboratories, Inc. for a BIORAD LABORATORIES QX200 SUPPORT PLAN MAINTENANCE/SERVICE CONTRACT. Bio-Rad Laboratories, Inc. will provide maintenance and service for a QX200 instrument under the contract, which runs from September 15, 2023 through September 14, 2024 and is being performed in Bethesda, Maryland....
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Bio-Rad Laboratories, Inc.'s Life Science Group Division. The $5,995 firm fixed-price purchase order, awarded on August 8, 2012, did not have a set-aside designation. The contract was for the delivery of unspecified products by the ultimate completion date of August 25, 2013. Bio-Rad Laboratories, Inc. is a global leader in...
- This firm fixed-price purchase order in the amount of $12,614 was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The contract does not have a set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in life science research and clinical diagnostic products. Under this contract, Bio-Rad will provide products and services to NIAID, which is part of the...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,613.30 firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for service agreements on a ChemiDoc system and Bio-Plex 200 instrument. This contract is not associated with a set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing life science research and clinical diagnostics...
- This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc., was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services (HHS). The $6,076.80 firm fixed-price purchase order, awarded on April 19, 2016, did not involve any set-aside designation. Bio-Rad, a global manufacturer of life science research and clinical diagnostics products, has...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Bio-Rad Laboratories, Inc. (Life Science Group) on May 30, 2019, for $11,995.00, with ultimate completion on June 12, 2019. The order carries firm fixed price pricing with no set-aside. Place of performance is Rodeo, California. The source does not specify the goods or services procured under this purchase order.</p>
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for the delivery of a CFX96 Touch Real-Time PCR Detection System. The contract, valued at $23,495.00, does not have a set-aside designation. As a leading supplier of life science research products and clinical diagnostic equipment, Bio-Rad has a 5-year, $1 billion blanket...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH/NIAID) awarded a firm-fixed-price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for an S3E cell sorter and associated equipment, training, and installation services. The total potential value of the contract is $149,995.00. The contract was awarded on August 20, 2018 with a completion date of August 19, 2019. No set-aside designation was used for this acquisition, which was conducted under Simplified Acquisition Procedures. Bio-Rad Laboratories holds a $1 billion, 5-year blanket purchase agreement with the NIH to provide biological materials, chemicals, consumables, and other supplies to support the agency's medical research programs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Bio-Rad Cell-Sorter | RFQ-NIAID-1923208 | Department of Health and Human Services National Institutes of Health | Solicitation 1/1 | 8/7/18, 5:10 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $150.0k | 8/20/18 |